Steven M. Fruchtman
2016
In 2016, Steven M. Fruchtman earned a total compensation of $691K as Chief Medical Officer and Senior Vice President, Research and Development at Onconova Therapeutics, a 24% decrease compared to previous year.
Compensation breakdown
| Bonus | $142,800 |
|---|---|
| Option Awards | $119,283 |
| Salary | $421,784 |
| Other | $7,179 |
| Total | $691,046 |
Fruchtman received $421.8K in salary, accounting for 61% of the total pay in 2016.
Fruchtman also received $142.8K in bonus, $119.3K in option awards and $7.2K in other compensation.
Rankings
In 2016, Steven M. Fruchtman's compensation ranked 9,939th out of 14,075 executives tracked by ExecPay. In other words, Fruchtman earned more than 29.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,939 out of 14,075 | 29th |
Division Manufacturing | 3,840 out of 5,489 | 30th |
Major group Chemicals And Allied Products | 1,346 out of 1,895 | 29th |
Industry group Drugs | 1,074 out of 1,538 | 30th |
Industry Pharmaceutical Preparations | 843 out of 1,176 | 28th |
Source: SEC filing on April 12, 2017.
Fruchtman's colleagues
We found two more compensation records of executives who worked with Steven M. Fruchtman at Onconova Therapeutics in 2016.
News
Onconova Therapeutics CEO Steven Fruchtman's 2023 pay slips 17% to $1.1M
October 11, 2024
Onconova Therapeutics CEO Steven Fruchtman's 2022 pay falls 50% to $1.3M
June 7, 2023
Onconova Therapeutics CEO Steven Fruchtman's 2021 pay jumps 159% to $2.7M
May 25, 2022
Onconova Therapeutics CEO Ramesh Kumar's 2018 pay jumps 82% to $1.2M
April 29, 2019